Literature DB >> 23164817

The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression.

Z Samaan1, S S Anand, S Anand, X Zhang, D Desai, M Rivera, G Pare, L Thabane, C Xie, H Gerstein, J C Engert, I Craig, S Cohen-Woods, V Mohan, R Diaz, X Wang, L Liu, T Corre, M Preisig, Z Kutalik, S Bergmann, P Vollenweider, G Waeber, S Yusuf, D Meyre.   

Abstract

Candidate gene and genome-wide association studies have not identified common variants, which are reliably associated with depression. The recent identification of obesity predisposing genes that are highly expressed in the brain raises the possibility of their genetic contribution to depression. As variation in the intron 1 of the fat mass- and obesity-associated (FTO) gene contributes to polygenic obesity, we assessed the possibility that FTO gene may contribute to depression in a cross-sectional multi-ethnic sample of 6561 depression cases and 21,932 controls selected from the EpiDREAM, INTERHEART, DeCC (depression case-control study) and Cohorte Lausannoise (CoLaus) studies. Major depression was defined according to DSM IV diagnostic criteria. Association analyses were performed under the additive genetic model. A meta-analysis of the four studies showed a significant inverse association between the obesity risk FTO rs9939609 A variant and depression (odds ratio=0.92 (0.89, 0.97), P=3 × 10(-4)) adjusted for age, sex, ethnicity/population structure and body-mass index (BMI) with no significant between-study heterogeneity (I(2)=0%, P=0.63). The FTO rs9939609 A variant was also associated with increased BMI in the four studies (β 0.30 (0.08, 0.51), P=0.0064) adjusted for age, sex and ethnicity/population structure. In conclusion, we provide the first evidence that the FTO rs9939609 A variant may be associated with a lower risk of depression independently of its effect on BMI. This study highlights the potential importance of obesity predisposing genes on depression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23164817     DOI: 10.1038/mp.2012.160

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  39 in total

1.  An Obesity-Predisposing Variant of the FTO Gene Regulates D2R-Dependent Reward Learning.

Authors:  Meltem Sevgi; Lionel Rigoux; Anne B Kühn; Jan Mauer; Leonhard Schilbach; Martin E Hess; Theo O J Gruendler; Markus Ullsperger; Klaas Enno Stephan; Jens C Brüning; Marc Tittgemeyer
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

2.  Do genetic risk scores for body mass index predict risk of phobic anxiety? Evidence for a shared genetic risk factor.

Authors:  S Walter; M M Glymour; K Koenen; L Liang; E J Tchetgen Tchetgen; M Cornelis; S-C Chang; M Rewak; E Rimm; I Kawachi; L D Kubzansky
Journal:  Psychol Med       Date:  2014-05-28       Impact factor: 7.723

3.  Association of FTO rs9939609 SNP with Obesity and Obesity- Associated Phenotypes in a North Indian Population.

Authors:  Jai Prakash; Balraj Mittal; Apurva Srivastava; Shally Awasthi; Neena Srivastava
Journal:  Oman Med J       Date:  2016-03

4.  Challenges in conducting genetic analyses based on data-driven classification of major depressive disorder.

Authors:  V-P Mäkinen
Journal:  Mol Psychiatry       Date:  2016-11-08       Impact factor: 15.992

Review 5.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

6.  Can familial factors account for the association of body mass index with poor mental health in men or women?

Authors:  Ellen Schur; Kathryn M Godfrey; Elizabeth Dansie; Dedra Buchwald; Sherry Pagoto; Niloofar Afari
Journal:  Gen Hosp Psychiatry       Date:  2013-05-10       Impact factor: 3.238

7.  The effect of FTO rs9939609 on major depression differs across MDD subtypes.

Authors:  Y Milaneschi; F Lamers; H Mbarek; J-J Hottenga; D I Boomsma; B W J H Penninx
Journal:  Mol Psychiatry       Date:  2014-02-04       Impact factor: 15.992

Review 8.  N6-methyladenosine as a Novel Regulator of Brain Physiology and Diseases.

Authors:  Bing Han; Hong-Hong Yao
Journal:  Curr Med Sci       Date:  2020-07-17

Review 9.  Epitranscriptomic regulation by m6A RNA methylation in brain development and diseases.

Authors:  Anil K Chokkalla; Suresh L Mehta; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-23       Impact factor: 6.200

10.  Bivariate Genome-Wide Association Study of Depressive Symptoms With Type 2 Diabetes and Quantitative Glycemic Traits.

Authors:  Kadri Haljas; Azmeraw T Amare; Behrooz Z Alizadeh; Yi-Hsiang Hsu; Thomas Mosley; Anne Newman; Joanne Murabito; Henning Tiemeier; Toshiko Tanaka; Cornelia van Duijn; Jingzhong Ding; David J Llewellyn; David A Bennett; Antonio Terracciano; Lenore Launer; Karl-Heinz Ladwig; Marylin C Cornelis; Alexander Teumer; Hans Grabe; Sharon L R Kardia; Erin B Ware; Jennifer A Smith; Harold Snieder; Johan G Eriksson; Leif Groop; Katri Räikkönen; Jari Lahti
Journal:  Psychosom Med       Date:  2018-04       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.